Effect of the new pyridoindole antioxidant SMe1EC2 on functional deficits and oedema formation in rat hippocampus exposed to ischaemia in vitro

Neuroendocrinology Letters

Volumn 30, Issue 5, 2009, Pages 574-581

  Gáspárová, Zdenka ^a   Janega, Pavol ^b,c   Babál, Pavel ^b   Šnirc, Vladimír ^a   Štolc, Svorad ^a,d   Mach, Mojmír ^a   Ujházy, Eduard ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c INSTITUTE OF CHEMISTRY   (Slovakia)

^d Biont as   (Slovakia)

Author keywords

Hippocampus; Hypoxia hypoglycaemia; Ischaemia; Neuronal transmission; Neuroprotection; Oedema; Pyridoindole antioxidant

Indexed keywords

2 ETHOXYCARBONYL 8 METHOXY 2,3,4,4A,5,9B HEXAHYDRO 1H PYRIDO (4,3B)INDOLINIUM CHLORIDE; ANTIOXIDANT; CARBOLINE DERIVATIVE; SME1EC2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HYPOGLYCEMIA; HYPOXIA; MALE; NONHUMAN; RAT;

EID: 77649268279     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bacigaluppi M, Hermann DM (2008). New targets of neuroprotection in ischaemic stroke. ScientificWorldJournal 8:698-712.
2. Barkov NK (1973). On the mechanism of action of carbidine. Pharmacol Toxicol. 36:154-157.
3. Chan PH (2001). Reactive oxygen species in signaling and damage in the ischaemic brain. Cereb Blood Flow Metab 21:2-14.
4. Ek RO, Zencirci SG, Dost T, Birincioglu M, Bilgin MD (2007). Effects of melatonin supplementary on the sciatic nerve conduction velocity in ovariectomized-aged rat. Neuroendocrinol Lett. 28: 666-670.
5. Fatokun AA, Stone TW, Smith RA (2008). Oxidative stress in neurodegeneration and available means of protection. Front Biosci. 13:3288-3311.
6. Gáspárová Z, Štolc S, Šnirc V (2006). In vitro physiological evidence of enhanced neuroprotective and antioxidant action of 2,3-dihydromelatonin: a melatonin analogue. Pharmacol Res. 53:22-27.
7. Ginsberg MD (2008). Neuroprotection for ischaemic stroke: past, present and future. Neuropharmacology. 55:363-389.
8. Gladstone DJ, Black SE, Hakim AM (2002). Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 33:2123-2136.
9. Hall ED, Andrus PK, Smith SL, Oostveen JA, Scherch HM, Lutzke BS, et al (1996). Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir. 66(Suppl):107-113.
10. Hall ED, Braughler JM, McCall JM (1992). Antioxidant effects in brain and spinal cord injury. J Neurotrauma 9(Suppl 1):S165-172.
11. Horáková L', Štolc S (1998). Antioxidant and pharmacodynamic effect of pyridoindole stobadine. Gen Pharmacol. 30:627-638.
12. Horáková L, Uraz V, Ondrejičková O, Lukovič L', Juránek I (1991). Effect of stobadine on brain lipid peroxidation induced by incomplete ischaemia and subsequent reperfusion. Biomed. Biochim Acta. 50:1019-1025.
13. Hossmann KA, Fischer M, Bockhorst K, Hoen-Berlage M (1994). NMR imaging of the apparent diffusion coefficient (ADC) for the evaluation of metabolic suppression and recovery after prolonged cerebral ischaemia. J. Cereb Blood Flow Metab. 14:723-731.
14. Kreisman NR, LaManna JC (1999). Rapid and slow swelling during hypoxia in the CA1 region of rat hippocampal slices. J Neurophysiol. 82:320-329.
15. Levi MS, Brimble MA (2004). A review of neuroprotective agents. Curr Med Chem. 11:2383-2397.
16. Liebeskind DS, Kasner SE (2001). Neuroprotection for ischaemic stroke: an unattainable goal? CNS Drugs. 15:165-174.
17. Nakajima R, Nakamura T, Ogawa M, Miyakawa H, Kudo Y (2004). Novel method for quantification of brain cell swelling in rat hippocampal slices. Neurosci Res. 76:723-733.
18. Nukada H, Dyck PJ (1987). Acute ischaemia cause axonal stasis, swelling, attenuation, and secondary demyelination. Ann Neurol. 22:311-318.
19. Payne RS, Schurr A, Rigor BM (1996). Cell swelling exacerbates hypoxic neuronal damage in rat hippocampal slices. Brain Res. 723:210-213.
20. Reiter RJ, Tan DX, Manchester LC, Tamura H (2007). Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol. 58(Suppl 6):5-22.
21. Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD (2008). Biogenicamines in the reduction of oxidative stress: melatonin and its metabolites. Neuroendocrinol Lett. 29:391-398.
22. Saito A, Maier CM, Narasimhan P, Nishi T, Song YS, Yu F, et al (2005). Oxidative stress and neuronal death/survival signaling in cerebral ischaemia. Mol Neurobiol. 31:105-116.
23. Savitz SI, Fisher M (2007). Future of neuroprotection for acute stroke:in the after math of the SAINT trials. Ann Neurol 61:396-402.
24. Siesjo BK (1988). Acidosis and ischaemic brain damage. Neurochem Pathol. 9:31-88.
25. Štolc S, Šnirc V, Májeková M, Gáspárová Z, Gajdošíková A, Štvrtina S (2006). Development of the new group of indole-derived neuroprotective drugs affecting oxidative stress. Cell Mol Neurobiol. 26:1493-1502.
26. Štolc S, Šnirc V, Gajdošíková A, Gajdošík A, Gáspárová Z, Ondrejič ková O, et al (2008). New pyridoindoles with antioxidant and neuroprotective actions. In: Bauer V, editor. Trends in pharmacological research. Bratislava, Institute of Experimental Pharmacology, p. 118-136.
27. Sugawara T, Chan PH (2003). Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischaemia. Antioxid Redox Signal. 5:597-607.
28. Ujházy E, Dubovický M, Ponechalová V, Navarová J, Brucknerová, J, Šnirc V, et al (2008). Prenatal developmental toxicity study of the pyridolindole antioxidant SMe1EC2 in rats. Neuroendocrinol Lett. 29:639-643.
29. Vlkolinský R, Štolc S (1999). Effect of stobadine, melatonin, and other antioxidants on hypoxia/reoxygenation-induced synaptic failure in rat hippocampal slices. Brain Res. 850:118-126.
30. Zhang L, Zhang Y, Tian GF, Wallace MC, Eubanks JH (1999). Reversible atttenuation of glutamatergic transmission in hippocampal CA1 neurons of rat brain slices following transient cerebral ischaemia. Brain Res. 832:31-39.
31. Wahlgren NG, Ahmed N (2004). Neuroprotection in cerebral ischaemia: facts and fancies-the need for new approaches. Cerebrovasc Dis. 17(Suppl 1):153-166.